This document is intended to answer clinician and healthcare provider questions and offer helpful ways to orient practices and navigate the diversion of prescribed safer supply medications.
This FAQ was developed by the collaborative Reframing Diversion Working Group of the National Safer Supply Community of Practice (NSS-CoP). The working group members hold diverse roles as stakeholders in health and social service provision, including physicians, physician assistants, nurse practitioners, nurses, people who use(d) drugs, researchers, program coordinators, and activists. The working group aims to define, critique, and shape emerging discourses of diversion, to educate healthcare providers on the different community practices of diversion, and to promote a person-centered care approach to risk mitigation.